Bilirubin Restrains the Anticancer Effect of Vemurafenib on BRAF-Mutant Melanoma Cells Through ERK-MNK1 Signaling

Melanoma, the most threatening cancer in the skin, has been considered to be driven by the carcinogenic RAF-MEK1/2-ERK1/2 signaling pathway. This signaling pathway is usually mainly dysregulated by mutations in BRAF or RAS in skin melanomas. Although inhibitors targeting mutant BRAF, such as vemuraf...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Yufan, Zhong, Xiaoyu, Wen, Xizhi, Yao, Leyi, Shao, Zhenlong, Sun, Wenshuang, Wu, Jiawen, Wen, Guanmei, Tang, Daolin, Zhang, Xiaoshi, Liao, Yuning, Liu, Jinbao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250144/
https://www.ncbi.nlm.nih.gov/pubmed/34222023
http://dx.doi.org/10.3389/fonc.2021.698888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250144/
https://www.ncbi.nlm.nih.gov/pubmed/34222023
http://dx.doi.org/10.3389/fonc.2021.698888

Ejemplares similares